{"entity":{"type":"insider","cik":"0001422645","url":"/insider/0001422645","json_url":"/insider/0001422645.json","name":"Johnston Robert F","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":18,"n_filings":13,"first":"2009-04-23","last":"2011-03-30","span_basis":"filed_date"},"name_variants":[{"name":"Johnston Robert F","source":"filing","n_filings":13,"first_seen":"2009-04-23","last_seen":"2011-03-30"}],"transactions":[{"id":9005467,"accession":"0001422645-11-000009","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001422645-11-000009","line_url":"/filing/0001422645-11-000009#line-1","is_derivative":false,"issuer_cik":"0000713275","issuer_name":"PHARMOS CORP","issuer_ticker":"PARS.PK","issuer_name_source":null,"issuer_url":"/issuer/0000713275","owner_cik":"0001422645","owner_name":"Johnston Robert F","owner_display_name":"Johnston Robert F","owner_url":"/insider/0001422645","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3628.0,"shares_display":"3,628","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":326.52,"total_display":"326.52","total_whole":"327","shares_owned_after":11946271.0,"shares_owned_after_display":"11,946,271","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-28","filed_date":"2011-03-30","scope":"insider"},{"id":8990337,"accession":"0001422645-11-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001422645-11-000008","line_url":"/filing/0001422645-11-000008#line-1","is_derivative":false,"issuer_cik":"0000713275","issuer_name":"PHARMOS CORP","issuer_ticker":"PARS.PK","issuer_name_source":null,"issuer_url":"/issuer/0000713275","owner_cik":"0001422645","owner_name":"Johnston Robert F","owner_display_name":"Johnston Robert F","owner_url":"/insider/0001422645","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":8999.0,"shares_display":"8,999","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":809.91,"total_display":"809.91","total_whole":"810","shares_owned_after":11942643.0,"shares_owned_after_display":"11,942,643","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-23","filed_date":"2011-03-25","scope":"insider"},{"id":8845959,"accession":"0001422645-11-000007","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001422645-11-000007","line_url":"/filing/0001422645-11-000007#line-1","is_derivative":false,"issuer_cik":"0000713275","issuer_name":"PHARMOS CORP","issuer_ticker":"PARS.PK","issuer_name_source":null,"issuer_url":"/issuer/0000713275","owner_cik":"0001422645","owner_name":"Johnston Robert F","owner_display_name":"Johnston Robert F","owner_url":"/insider/0001422645","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":81708.0,"shares_display":"81,708","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":7353.72,"total_display":"7,353.72","total_whole":"7,354","shares_owned_after":11933644.0,"shares_owned_after_display":"11,933,644","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-22","filed_date":"2011-03-22","scope":"insider"},{"id":9057826,"accession":"0001422645-11-000006","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001422645-11-000006","line_url":"/filing/0001422645-11-000006#line-1","is_derivative":false,"issuer_cik":"0000713275","issuer_name":"PHARMOS CORP","issuer_ticker":"PARS.PK","issuer_name_source":null,"issuer_url":"/issuer/0000713275","owner_cik":"0001422645","owner_name":"Johnston Robert F","owner_display_name":"Johnston Robert F","owner_url":"/insider/0001422645","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":57015.0,"shares_display":"57,015","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":5131.35,"total_display":"5,131.35","total_whole":"5,131","shares_owned_after":11851936.0,"shares_owned_after_display":"11,851,936","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-21","filed_date":"2011-03-22","scope":"insider"},{"id":9106081,"accession":"0001422645-11-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001422645-11-000005","line_url":"/filing/0001422645-11-000005#line-1","is_derivative":false,"issuer_cik":"0000713275","issuer_name":"PHARMOS CORP","issuer_ticker":"PARS.PK","issuer_name_source":null,"issuer_url":"/issuer/0000713275","owner_cik":"0001422645","owner_name":"Johnston Robert F","owner_display_name":"Johnston Robert F","owner_url":"/insider/0001422645","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":42910.0,"shares_display":"42,910","price_per_share":0.09,"price_display":"0.09","price_state":"stated","total_value":3861.9,"total_display":"3,861.90","total_whole":"3,862","shares_owned_after":11794921.0,"shares_owned_after_display":"11,794,921","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-08","filed_date":"2011-03-10","scope":"insider"},{"id":9106080,"accession":"0001422645-11-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001422645-11-000004","line_url":"/filing/0001422645-11-000004#line-1","is_derivative":false,"issuer_cik":"0000713275","issuer_name":"PHARMOS CORP","issuer_ticker":"PARS.PK","issuer_name_source":null,"issuer_url":"/issuer/0000713275","owner_cik":"0001422645","owner_name":"Johnston Robert F","owner_display_name":"Johnston Robert F","owner_url":"/insider/0001422645","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4590.0,"shares_display":"4,590","price_per_share":0.085,"price_display":"0.08","price_state":"stated","total_value":390.15,"total_display":"390.15","total_whole":"390","shares_owned_after":11752011.0,"shares_owned_after_display":"11,752,011","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-03","filed_date":"2011-03-07","scope":"insider"},{"id":9005466,"accession":"0001422645-11-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001422645-11-000003","line_url":"/filing/0001422645-11-000003#line-1","is_derivative":false,"issuer_cik":"0000713275","issuer_name":"PHARMOS CORP","issuer_ticker":"PARS.PK","issuer_name_source":null,"issuer_url":"/issuer/0000713275","owner_cik":"0001422645","owner_name":"Johnston Robert F","owner_display_name":"Johnston Robert F","owner_url":"/insider/0001422645","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":52500.0,"shares_display":"52,500","price_per_share":0.0895,"price_display":"0.09","price_state":"stated","total_value":4698.75,"total_display":"4,698.75","total_whole":"4,699","shares_owned_after":11747421.0,"shares_owned_after_display":"11,747,421","ownership_form":"I","is_10b5_1":null,"transaction_date":"2011-03-01","filed_date":"2011-03-03","scope":"insider"},{"id":9106079,"accession":"0001422645-11-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001422645-11-000001","line_url":"/filing/0001422645-11-000001#line-2","is_derivative":false,"issuer_cik":"0000713275","issuer_name":"PHARMOS CORP","issuer_ticker":"PARS","issuer_name_source":null,"issuer_url":"/issuer/0000713275","owner_cik":"0001422645","owner_name":"Johnston Robert F","owner_display_name":"Johnston Robert F","owner_url":"/insider/0001422645","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":20000.0,"shares_display":"20,000","price_per_share":0.0999,"price_display":"0.10","price_state":"stated","total_value":1998.0,"total_display":"1,998.00","total_whole":"1,998","shares_owned_after":11694567.0,"shares_owned_after_display":"11,694,567","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-30","filed_date":"2011-01-03","scope":"insider"},{"id":9106078,"accession":"0001422645-11-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001422645-11-000001","line_url":"/filing/0001422645-11-000001#line-1","is_derivative":false,"issuer_cik":"0000713275","issuer_name":"PHARMOS CORP","issuer_ticker":"PARS","issuer_name_source":null,"issuer_url":"/issuer/0000713275","owner_cik":"0001422645","owner_name":"Johnston Robert F","owner_display_name":"Johnston Robert F","owner_url":"/insider/0001422645","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":54000.0,"shares_display":"54,000","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":5400.0,"total_display":"5,400.00","total_whole":"5,400","shares_owned_after":11674567.0,"shares_owned_after_display":"11,674,567","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-29","filed_date":"2011-01-03","scope":"insider"},{"id":7653302,"accession":"0001422645-10-000005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001422645-10-000005","line_url":"/filing/0001422645-10-000005#line-1","is_derivative":false,"issuer_cik":"0000713275","issuer_name":"PHARMOS CORP","issuer_ticker":"PARS","issuer_name_source":null,"issuer_url":"/issuer/0000713275","owner_cik":"0001422645","owner_name":"Johnston Robert F","owner_display_name":"Johnston Robert F","owner_url":"/insider/0001422645","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":81190.0,"shares_display":"81,190","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":8119.0,"total_display":"8,119.00","total_whole":"8,119","shares_owned_after":11620567.0,"shares_owned_after_display":"11,620,567","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-23","filed_date":"2010-12-27","scope":"insider"},{"id":7572574,"accession":"0001422645-10-000004","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001422645-10-000004","line_url":"/filing/0001422645-10-000004#line-3","is_derivative":false,"issuer_cik":"0000713275","issuer_name":"PHARMOS CORP","issuer_ticker":"PARS","issuer_name_source":null,"issuer_url":"/issuer/0000713275","owner_cik":"0001422645","owner_name":"Johnston Robert F","owner_display_name":"Johnston Robert F","owner_url":"/insider/0001422645","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4970.0,"shares_display":"4,970","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":497.0,"total_display":"497.00","total_whole":"497","shares_owned_after":11539377.0,"shares_owned_after_display":"11,539,377","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-22","filed_date":"2010-12-22","scope":"insider"},{"id":7572573,"accession":"0001422645-10-000004","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001422645-10-000004","line_url":"/filing/0001422645-10-000004#line-2","is_derivative":false,"issuer_cik":"0000713275","issuer_name":"PHARMOS CORP","issuer_ticker":"PARS","issuer_name_source":null,"issuer_url":"/issuer/0000713275","owner_cik":"0001422645","owner_name":"Johnston Robert F","owner_display_name":"Johnston Robert F","owner_url":"/insider/0001422645","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7000.0,"shares_display":"7,000","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":700.0,"total_display":"700.00","total_whole":"700","shares_owned_after":11534407.0,"shares_owned_after_display":"11,534,407","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-21","filed_date":"2010-12-22","scope":"insider"},{"id":7572572,"accession":"0001422645-10-000004","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001422645-10-000004","line_url":"/filing/0001422645-10-000004#line-1","is_derivative":false,"issuer_cik":"0000713275","issuer_name":"PHARMOS CORP","issuer_ticker":"PARS","issuer_name_source":null,"issuer_url":"/issuer/0000713275","owner_cik":"0001422645","owner_name":"Johnston Robert F","owner_display_name":"Johnston Robert F","owner_url":"/insider/0001422645","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6840.0,"shares_display":"6,840","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":684.0,"total_display":"684.00","total_whole":"684","shares_owned_after":11527407.0,"shares_owned_after_display":"11,527,407","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-12-20","filed_date":"2010-12-22","scope":"insider"},{"id":7617895,"accession":"0001422645-10-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001422645-10-000003","line_url":"/filing/0001422645-10-000003","is_derivative":false,"issuer_cik":"0000713275","issuer_name":"PHARMOS CORP","issuer_ticker":"PARS.PK","issuer_name_source":null,"issuer_url":"/issuer/0000713275","owner_cik":"0001422645","owner_name":"Johnston Robert F","owner_display_name":"Johnston Robert F","owner_url":"/insider/0001422645","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":57000.0,"shares_display":"57,000","price_per_share":0.07440350877192982,"price_display":"0.07","price_state":"stated","total_value":4241.0,"total_display":"4,241.00","total_whole":"4,241","shares_owned_after":11497567.0,"shares_owned_after_display":"11,497,567","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-08-10","filed_date":"2010-08-12","scope":"insider","n_lines":2},{"id":7454323,"accession":"0001422645-10-000001","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001422645-10-000001","line_url":"/filing/0001422645-10-000001#line-2","is_derivative":false,"issuer_cik":"0000713275","issuer_name":"PHARMOS CORP","issuer_ticker":"PARS.PK","issuer_name_source":null,"issuer_url":"/issuer/0000713275","owner_cik":"0001422645","owner_name":"Johnston Robert F","owner_display_name":"Johnston Robert F","owner_url":"/insider/0001422645","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":244382.0,"shares_display":"244,382","price_per_share":0.0597,"price_display":"0.06","price_state":"stated","total_value":14589.6054,"total_display":"14,589.61","total_whole":"14,590","shares_owned_after":11463567.0,"shares_owned_after_display":"11,463,567","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-06-03","filed_date":"2010-06-04","scope":"insider"},{"id":7454321,"accession":"0001422645-10-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001422645-10-000001","line_url":"/filing/0001422645-10-000001#line-1","is_derivative":false,"issuer_cik":"0000713275","issuer_name":"PHARMOS CORP","issuer_ticker":"PARS.PK","issuer_name_source":null,"issuer_url":"/issuer/0000713275","owner_cik":"0001422645","owner_name":"Johnston Robert F","owner_display_name":"Johnston Robert F","owner_url":"/insider/0001422645","role":"Director, Officer (Executive Chairman), Ten percent owner","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"common stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":350000.0,"shares_display":"350,000","price_per_share":0.0642,"price_display":"0.06","price_state":"stated","total_value":22470.0,"total_display":"22,470.00","total_whole":"22,470","shares_owned_after":11707949.0,"shares_owned_after_display":"11,707,949","ownership_form":"I","is_10b5_1":null,"transaction_date":"2010-06-02","filed_date":"2010-06-04","scope":"insider"},{"id":6067664,"accession":"0001422645-09-000003","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001422645-09-000003","line_url":"/filing/0001422645-09-000003#line-2","is_derivative":false,"issuer_cik":"0000713275","issuer_name":"PHARMOS CORP","issuer_ticker":"PARS.PK","issuer_name_source":null,"issuer_url":"/issuer/0000713275","owner_cik":"0001422645","owner_name":"Johnston Robert F","owner_display_name":"Johnston Robert F","owner_url":"/insider/0001422645","role":"Director, Officer (Executive Chairman)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Executive Chairman","security_title":"common stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6000000.0,"shares_display":"6,000,000","price_per_share":0.1,"price_display":"0.10","price_state":"stated","total_value":600000.0,"total_display":"600,000.00","total_whole":"600,000","shares_owned_after":7043099.0,"shares_owned_after_display":"7,043,099","ownership_form":"I","is_10b5_1":null,"transaction_date":"2009-04-21","filed_date":"2009-04-23","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":18,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":16,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":18},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000713275","name":"PHARMOS CORP","url":"/issuer/0000713275","role":"Director, Officer (Executive Chairman), Ten percent owner","n_filings":13,"first_seen":"2009-04-23","last_seen":"2011-03-30"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001422645","retrieved_at":"2026-08-23T19:18:51+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}